{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:09:14Z","timestamp":1793372954043,"version":"4.5.0"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Chronic myeloproliferative neoplasms encompass the BCR-ABL1-negative neoplasms polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). These are characterized by calreticulin (CALR), myeloproliferative leukemia virus proto-oncogene (MPL) and the tyrosine kinase Janus kinase 2 (JAK2) mutations, eventually establishing a hyperinflammatory tumor microenvironment (TME). Several reports have come to describe how constitutive activation of JAK-STAT and NF\u03baB signaling pathways lead to uncontrolled myeloproliferation and pro-inflammatory cytokines secretion. In such a highly oxidative TME, the balance between Hematopoietic Stem Cells (HSCs) and Mesenchymal Stromal Cells (MSCs) has a crucial role in MPN development. For this reason, we sought to review the current literature concerning the interplay between HSCs and MSCs. The latter have been reported to play an outstanding role in establishing of the typical bone marrow (BM) fibrotic TME as a consequence of the upregulation of different fibrosis-associated genes including PDGF- \u03b2 upon their exposure to the hyperoxidative TME characterizing MPNs. Therefore, MSCs might turn to be valuable candidates for niche-targeted targeting the synthesis of cytokines and oxidative stress in association with drugs eradicating the hematopoietic clone.<\/jats:p>","DOI":"10.3389\/fonc.2023.1141610","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T07:42:22Z","timestamp":1677138142000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases"],"prefix":"10.3389","volume":"13","author":[{"given":"Enrico","family":"La Spina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Giallongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesarina","family":"Giallongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzio","family":"Vicario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Duminuco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Longhitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Li Volti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cambria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Alberto","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Tibullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2012.12.013","article-title":"Myeloproliferative neoplasms related glomerulopathy","volume":"34","author":"Paule","year":"2013","journal-title":"Rev Med Interne"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24440","article-title":"The 2008 world health organization classification system for myeloproliferative neoplasms: order out of chaos","volume":"115","author":"Tefferi","year":"2009","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/sj.leu.2404955","article-title":"Classification and diagnosis of myeloproliferative neoplasms: the 2008 world health organization criteria and point-of-care diagnostic algorithms","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.humpath.2008.02.004","article-title":"The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised world health organization diagnostic criteria for myeloproliferative neoplasms","volume":"39","author":"Smith","year":"2008","journal-title":"Hum Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.119","article-title":"The myelodysplastic\/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features","volume":"22","author":"Orazi","year":"2008","journal-title":"Leukemia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bbmt.2006.11.003","article-title":"Philadelphia Chromosome-negative myeloproliferative disorders: biology and treatment","volume":"13","author":"Hoffman","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3324\/haematol.2014.113845","article-title":"Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms","volume":"102","author":"Grinfeld","year":"2017","journal-title":"Haematologica"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e578","DOI":"10.1097\/HS9.0000000000000578","article-title":"Functional consequences of mutations in myeloproliferative neoplasms","volume":"5","author":"Constantinescu","year":"2021","journal-title":"Hemasphere"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06497.x","article-title":"The JAK2 V617F mutation involves b- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders","volume":"136","author":"Larsen","year":"2007","journal-title":"Br J Haematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.268","article-title":"Oxidative stress-induced calreticulin expression and translocation: new insights into the destruction of melanocytes","volume":"134","author":"Zhang","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1038\/s41467-020-17380-5","article-title":"Magnetic field boosted ferroptosis-like cell death and responsive MRI using hybrid vesicles for cancer immunotherapy","volume":"11","author":"Yu","year":"2020","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41419-020-2304-8","article-title":"Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia","volume":"11","author":"Song","year":"2020","journal-title":"Cell Death Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2020.01.011","article-title":"Calreticulin protects insulin against reductive stress in vitro and in MIN6 cells","author":"Ikezaki","year":"2020","journal-title":"Biochimie"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1042\/bj3440281","article-title":"Calreticulin: one protein, one gene, many functions","volume":"344","author":"Michalak","year":"1999","journal-title":"Biochem J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2012.02.009","article-title":"Calreticulin signaling in health and disease","volume":"44","author":"Wang","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-3-030-67696-4_2","article-title":"Structural analysis of calreticulin, an endoplasmic reticulum-resident molecular chaperone","volume":"59","author":"Houen","year":"2021","journal-title":"Prog Mol Subcell Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.17.13089","article-title":"Functional relationship between calreticulin, calnexin, and the endoplasmic reticulum luminal domain of calnexin","volume":"275","author":"Danilczyk","year":"2000","journal-title":"J Biol Chem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00075.2005","article-title":"Role of calreticulin in the sensitivity of myocardiac H9c2 cells to oxidative stress caused by hydrogen peroxide","volume":"290","author":"Ihara","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3777","article-title":"Unfolding the role of calreticulin in myeloproliferative neoplasm pathogenesis","volume":"25","author":"Merlinsky","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000622","article-title":"Mutant calreticulin in myeloproliferative neoplasms","volume":"134","author":"How","year":"2019","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000333","article-title":"Mutant calreticulin in the myeloproliferative neoplasms","volume":"4","author":"Prins","year":"2020","journal-title":"Hemasphere"},{"key":"B25","doi-asserted-by":"publisher","first-page":"blood.2022017416","DOI":"10.1182\/blood.2022017416","article-title":"Biology and therapeutic targeting of molecular mechanisms in MPN","volume":"19","author":"How","year":"2022","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-530865","article-title":"From janus kinase 2 to calreticulin: the clinically relevant genomic landscape of myeloproliferative neoplasms","volume":"123","author":"Cazzola","year":"2014","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2020.02.003","article-title":"Reactivation of tuberculosis following ruxolitinib therapy for primary myelofibrosis: Case series and literature review","volume":"14","author":"Khalid","year":"2021","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.277","article-title":"Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms","volume":"30","author":"Pietra","year":"2016","journal-title":"Leukemia"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2864","article-title":"Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases","volume":"105","author":"Mesa","year":"2005","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M005727200","article-title":"Calmodulin differentially modulates Smad1 and Smad2 signaling","volume":"275","author":"Scherer","year":"2000","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-618595","article-title":"Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells","volume":"126","author":"Lu","year":"2015","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3696","article-title":"Osteogenic potential of mesenchymal stromal cells contributes to primary myelofibrosis","volume":"75","author":"Martinaud","year":"2015","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2010.05603.x","article-title":"Mechanisms of oxidant generation by catalase","volume":"1203","author":"Heck","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2012.10.020","article-title":"Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. a human inflammation model for cancer development","volume":"37","author":"Hasselbalch","year":"2013","journal-title":"Leuk Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-020-05950-1","article-title":"Connexin expression decreases during adipogenic differentiation of human adipose-derived mesenchymal stem cells","volume":"47","author":"Mannino","year":"2020","journal-title":"Mol Biol Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1258\/ebm.2011.011183","article-title":"Mesenchymal stem cells from adipose tissue which have been differentiated into chondrocytes in three-dimensional culture express lubricin","volume":"236","author":"Musumeci","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26192","article-title":"Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases","volume":"233","author":"Lo Furno","year":"2018","journal-title":"J Cell Physiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41419-019-1959-5","article-title":"TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma","volume":"10","author":"Giallongo","year":"2019","journal-title":"Cell Death Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.745653","article-title":"Mesenchymal stromal cell-derived extracellular vesicles promote myeloid-biased multipotent hematopoietic progenitor expansion via toll-like receptor engagement","volume":"291","author":"Goloviznina","year":"2016","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9111037","article-title":"Synergic crosstalk between inflammation, oxidative stress, and genomic alterations in BCR-ABL-Negative myeloproliferative neoplasm","volume":"9","author":"Allegra","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/PL00000801","article-title":"The suppressors of cytokine signalling (SOCS)","volume":"58","author":"Kile","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.it.2009.09.009","article-title":"Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function","volume":"30","author":"Palmer","year":"2009","journal-title":"Trends Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cmet.2020.09.001","article-title":"Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy","volume":"32","author":"Forte","year":"2020","journal-title":"Cell Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtv.2013.08.002","article-title":"Cutaneous ulcers associated with hydroxyurea therapy","volume":"22","author":"Quattrone","year":"2013","journal-title":"J Tissue Viability"},{"key":"B45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/TCRM.S23277","article-title":"Ruxolitinib for the treatment of myelofibrosis: its clinical potential","volume":"8","author":"Ostojic","year":"2012","journal-title":"Ther Clin Risk Manag"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1579323","article-title":"Ruxolitinib treatment reduces monocytic superoxide radical formation without affecting hydrogen peroxide formation or systemic oxidative nucleoside damage in myelofibrosis","volume":"60","author":"Bjorn","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154092","article-title":"TGF-beta signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche","volume":"132","author":"Yao","year":"2022","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15526","article-title":"Transforming growth factor beta-mediated micromechanics modulates disease progression in primary myelofibrosis","volume":"24","author":"Teodorescu","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12387","article-title":"Role of TGF-beta1\/miR-382-5p\/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis","volume":"12","author":"Rossi","year":"2018","journal-title":"Mol Oncol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.cell.2019.04.040","article-title":"A cellular taxonomy of the bone marrow stroma in homeostasis and leukemia","volume":"177","author":"Baryawno","year":"2019","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1104-8","article-title":"The bone marrow microenvironment at single-cell resolution","volume":"569","author":"Tikhonova","year":"2019","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2018.068","article-title":"Megakaryocyte contribution to bone marrow fibrosis: many arrows in the quiver","volume":"10","author":"Malara","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.stem.2020.11.004","article-title":"Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis","volume":"28","author":"Leimkuhler","year":"2021","journal-title":"Cell Stem Cell"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3530","article-title":"Leptin-receptor-expressing bone marrow stromal cells are myofibroblasts in primary myelofibrosis","volume":"19","author":"Decker","year":"2017","journal-title":"Nat Cell Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.784401","article-title":"Fibrocytes: A critical review and practical guide","volume":"12","author":"Reinhardt","year":"2021","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/gels6040033","article-title":"Matrix remodeling and hyaluronan production by myofibroblasts and cancer-associated fibroblasts in 3D collagen matrices","volume":"6","author":"Sapudom","year":"2020","journal-title":"Gels"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020323","article-title":"Ixazomib improves bone remodeling and counteracts sonic hedgehog signaling inhibition mediated by myeloma cells","volume":"12","author":"Tibullo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203779","article-title":"IGFBP-6\/sonic hedgehog\/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis","volume":"13","author":"Longhitano","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.141283","article-title":"Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies","volume":"101","author":"Zahr","year":"2016","journal-title":"Haematologica"},{"key":"B60","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.stem.2017.03.008","article-title":"Gli1(+) mesenchymal stromal cells are a key driver of bone marrow fibrosis and an important cellular therapeutic target","volume":"20","author":"Schneider","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-02-834820","article-title":"The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis","volume":"131","author":"Kramann","year":"2018","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nature13383","article-title":"Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms","volume":"512","author":"Arranz","year":"2014","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10040806","article-title":"The hallmarks of glioblastoma: Heterogeneity, intercellular crosstalk and molecular signature of invasiveness and progression","volume":"10","author":"Torrisi","year":"2022","journal-title":"Biomedicines"},{"key":"B65","doi-asserted-by":"publisher","first-page":"101611","DOI":"10.1016\/j.redox.2020.101611","article-title":"Iron regulates myeloma cell\/macrophage interaction and drives resistance to bortezomib","volume":"36","author":"Camiolo","year":"2020","journal-title":"Redox Biol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/biom11010122","article-title":"Focus on osteosclerotic progression in primary myelofibrosis","volume":"11","author":"Spampinato","year":"2021","journal-title":"Biomolecules"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-1383(16)47003-8","article-title":"Bone mechanical properties and changes with osteoporosis","author":"Osterhoff","year":"2016","journal-title":"Injury"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nature12984","article-title":"The bone marrow niche for haematopoietic stem cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.08.025","article-title":"Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment","volume":"131","author":"Sacchetti","year":"2007","journal-title":"Cell"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30562","article-title":"Adult stem cell niches for tissue homeostasis","volume":"237","author":"Mannino","year":"2022","journal-title":"J Cell Physiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.acthis.2014.09.008","article-title":"Biosynthesis of collagen I, II, RUNX2 and lubricin at different time points of chondrogenic differentiation in a 3D in vitro model of human mesenchymal stem cells derived from adipose tissue","volume":"116","author":"Musumeci","year":"2014","journal-title":"Acta Histochem"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v6.i5.526","article-title":"Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy","volume":"6","author":"Glenn","year":"2014","journal-title":"World J Stem Cells"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2012.02.003","article-title":"Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration","volume":"10","author":"Park","year":"2012","journal-title":"Cell Stem Cell"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-878926","article-title":"Myelofibrosis osteoclasts are clonal and functionally impaired","volume":"133","author":"Veletic","year":"2019","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.06.009","article-title":"Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche","volume":"13","author":"Schepers","year":"2013","journal-title":"Cell Stem Cell"},{"key":"B76","doi-asserted-by":"publisher","first-page":"415024","DOI":"10.1155\/2015\/415024","article-title":"Inflammation as a keystone of bone marrow stroma alterations in primary myelofibrosis","volume":"2015","author":"Desterke","year":"2015","journal-title":"Mediators Inflammation"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.683401","article-title":"Inflammatory pathophysiology as a contributor to myeloproliferative neoplasms","volume":"12","author":"Fisher","year":"2021","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13123093","article-title":"Transforming growth factor-beta and oxidative stress in cancer: A crosstalk in driving tumor transformation","volume":"13","author":"Ramundo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1507709112","article-title":"Intrinsic mutagenic properties of 5-chlorocytosine: A mechanistic connection between chronic inflammation and cancer","volume":"112","author":"Fedeles","year":"2015","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1222669110","article-title":"Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease","volume":"110","author":"Knutson","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1207829109","article-title":"Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer","volume":"109","author":"Mangerich","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4419-9967-2_1","article-title":"DNA Methyltransferases, DNA damage repair, and cancer","volume":"754","author":"Jin","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/biology10070659","article-title":"Phosphorylation within intrinsic disordered region discriminates histone variant macroH2A1 splicing isoforms-macroH2A1.1 and macroH2A1.2","volume":"10","author":"Giallongo","year":"2021","journal-title":"Biol (Basel)"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315218","article-title":"The role of epigenetics in neuroinflammatory-driven diseases","volume":"23","author":"Giallongo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01516-3","article-title":"Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils","volume":"433","author":"Van den Worm","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gki612","article-title":"5-halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2)","volume":"33","author":"Valinluck","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S275595","article-title":"Reactive oxygen species: Drivers of physiological and pathological processes","volume":"13","author":"Checa","year":"2020","journal-title":"J Inflammation Res"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2015.07.007","article-title":"Inflammation-induced emergency megakaryopoiesis driven by hematopoietic stem cell-like megakaryocyte progenitors","volume":"17","author":"Haas","year":"2015","journal-title":"Cell Stem Cell"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2018.11.012","article-title":"Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter","volume":"76","author":"Di Veroli","year":"2019","journal-title":"Leuk Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-019-00508-w","article-title":"Key role of inflammation in myeloproliferative neoplasms: Instigator of disease initiation, progression. and symptoms","volume":"14","author":"Mendez Luque","year":"2019","journal-title":"Curr Hematol Malig Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1141610\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T07:42:25Z","timestamp":1677138145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1141610\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":90,"alternative-id":["10.3389\/fonc.2023.1141610"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1141610","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"article-number":"1141610"}}